FIELD: medicine immunobiological preparations.
SUBSTANCE: claimed method includes passivation of vaccine virus on 12-13-day hen embryos, lyophilization with 15 % of lactose, grinding, blending with recipient and pressing (palletizing) to produce preparation comprising up to 30 % of dry virus-containing material and recipient containing (%): lactose 87.8; sucrose 10; calcium stearate 2.0 and vanilla 0.2 %.
EFFECT: simplified method for production of pelletized embryonic variolar living vaccine.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LIVE RECOMBINANT VACCINE OF HEPATITIS B BASED ON SMALLPOX VIRUS FOR ORAL USE AND METHOD OF ITS PREPARING | 1994 |
|
RU2076735C1 |
| LIVE RECOMBINANT VACCINE FOR PROPHYLACTIC OF HEPATITIS B AND SMALLPOX FOR EPICUTANEOUS APPLICATION AND METHOD FOR ITS PRODUCTION | 1992 |
|
RU2073524C1 |
| INACTIVATED FETAL DRY TABLETED SMALLPOX VACCINE FOR ORAL ADMINISTRATION OF “THAOVIN” AND A METHOD FOR ITS PREPARATION | 2016 |
|
RU2651040C2 |
| LIVE ATTENUATED CULTURE VACCINE FOR PREVENTION OF SMALLPOX AND OTHER ORTHOPOXVIRUS INFECTIONS BASED ON SMALLPOX VACCINE VIRUS AND METHODS FOR ITS PREPARATION AND APPLICATION | 2022 |
|
RU2781070C1 |
| KIT OF TABLETTED ALIVE RECOMBINANT ORAL BIVACCINE AGAINST SMALLPOX AND HEPATITIS B AND METHOD FOR VACCINATION AT APPLYING THE KIT MENTIONED | 2005 |
|
RU2302259C2 |
| A METHOD OF OBTAINING A SMALLPOX INACTIVATED EMBRYONIC DRY VACCINE IN TABLET FORM FOR ORAL ADMINISTRATION | 2020 |
|
RU2744707C1 |
| TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING | 2002 |
|
RU2242246C2 |
| METHOD FOR PREPARING INACTIVATED DRY SMALLPOX VACCINE "OSPAVIR" | 2004 |
|
RU2259214C1 |
| AGENT FOR ARRESTING UNDESIRABLE VACCINAL REACTIONS AND COMPLICATIONS DURING PRIMARY VACCINATION WITH VARIOLAR VACCINES AND METHOD FOR USE THEREOF | 2013 |
|
RU2542490C1 |
| A DRY ASSOCIATED CULTURE VIRUS VACCINE AGAINST AVIAN NEWCASTLE DISEASE AND SMALLPOX | 2005 |
|
RU2295357C1 |
